Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Regression Models and Life-Tables
1992 • 27,454 citations
Evaluation of survival data and two new rank order statistics arising in its consideration.
1966 • 7,595 citations
Maximum utilization of the life table method in analyzing survival
1958 • 2,937 citations
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 • 2,084 citations
Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer
1995 • 1,480 citations
Forcing a sequential experiment to be balanced
1971 • 829 citations
Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen
1981 • 289 citations
Testing Goodness of Fit of Cox's Regression and Life Model
1982 • 246 citations
Lumpectomy and axillary dissection for breast cancer: Surgical, pathological, and radiation considerations
1985 • 73 citations
Comparison of Adjuvant Chemotherapy With Methotrexate and Fluorouracil With and Without Cyclophosphamide in Breast Cancer Patients With One to Three Positive Axillary Lymph Nodes
1993 • 12 citations
Cited By (0)
No citing papers found in database